Longevity Bayan ganewar asali
Idan kai ko wanda kake ƙaunata an gano shi tare da amyotrophic lateral sclerosis (ALS), wanda ake kira Lou Gehrig cutar, daya daga cikin tambayoyinku shine maganin cutar. ALS yana da tasirin gaske a kan yanayin rayuwa amma akwai jiyya wanda zai iya rage hasara na aiki na jiki kuma zai iya ƙara rayuwa.
Menene ALS?
ALS shine cutar neurodegenerative da ke shafar kwayoyin daji a cikin kwakwalwa da ƙwararre.
Sakamakon ci gaba ne wanda ke rinjayar matuka na motoci da ke fitowa daga kwakwalwa zuwa kashin baya. Wadannan ƙwayoyin suna sarrafa tsokoki cikin jiki. Yawancin lokaci, kwakwalwa ya rasa ikonsa na sarrafa karfin motsi saboda mutuwar waɗannan motocin motar.
Rayuwar Rayuwa ta ALS
Rayuwa mai rai na mutum tare da ALS shine shekaru biyu zuwa biyar daga lokacin ganewar asali. Duk da haka, ya bambanta sosai:
- Fiye da kashi 50 na mutanen da ALS ke rayuwa fiye da shekaru uku.
- Shekaru ashirin cikin shekaru biyar ko fiye.
- Kashi goma cikin shekaru 10 ko fiye.
- Rabin kashi zai rayu fiye da shekaru 20.
Hanyoyin da za su kara Rayuwa ta Rayuwa
Yayinda babu maganin ALS ko hanyoyin da za a dakatar da cigaba da cutar gaba ɗaya, akwai wasu abubuwa da za ku iya yi domin inganta rayuwar rai. Wadannan sun haɗa da:
- Magani: An yi amfani da Riluzole tun shekarar 1995 kuma an nuna shi a cikin gwajin gwaji na biyu wanda aka bazu don tsawaita rai tsawon kimanin watanni biyu zuwa uku, kodayake wasu, ƙananan bincike sun nuna magungunan ƙwayoyi sunyi tasiri kadan. Bugu da ƙari, ana amfani da wasu magunguna don gudanar da alamar alaƙa wanda zai iya taimakawa wajen kyautata rayuwar rayuwa da kuma tsawan aiki. Radicava (edaravone) an amince da ita a shekara ta 2017. A cikin gwaji, ya rage karuwar aikin aiki.
- Ƙunƙarar Nuna Nuna: An yi amfani da iska mai ban sha'awa (NEV) don tsawaita rai tsakanin watanni bakwai da 11, dangane da tsawon lokacin da aka yi amfani da shi a kowace rana da kuma halaye daban-daban. Hanyar farko ta NEV tana da iska mai mahimmanci, wanda yake da numfashi ta hanyar kariya wanda ya dace da baki da hanci.
- Gizon Gastronomy (PEG) wanda ya ɓoye shi: An saka jariri mai ciki a cikin ciki kuma yana fitar da jiki daga cikin rufin ciki. Kodayake nazarin ya kasa nuna alamar tasiri akan rayuwar zaman rayuwa, Cibiyar Nazarin Kwayoyin Nahiyar Amirka ta bayar da shawarar cewa ana amfani da PEG ga mutanen da ke tare da ALS don ci gaba da kasancewa a cikin jiki. Dabbobi daban-daban suna da ra'ayoyi daban-daban a lokacin da lokaci mafi kyau don yin hanyar PEG kuma za su fara ciyar da wannan hanya.
Kalma Daga
An samu ci gaba a cikin 'yan shekarun nan a goyan baya da kuma kulawa ga ALS. Yin ilimin kan kanka a kan maganin kulawa da kulawa na ALS zai iya taimaka maka ka gane wannan ganewar da wuya da rikitarwa. Yi magana da likitanku game da abin da za a iya yi don taimakawa mutumin da ke tare da ALS zama mafi dacewa har tsawon lokacin da zai yiwu.
Sources:
> Facts Ya kamata Ka sani game da ALS. Kungiyar ALS. http://www.alsa.org/about-als/facts-you-should-know.html.
> Tambayoyi akai-akai game da Radicava (Edaravone). Kungiyar ALS. http://www.alsa.org/research/radicava/radicava-frequently-asked-questions.html.
> Miller RG, et. al. Yi amfani da sabuntawa na zamani: Kulawa da mai haƙuri tare da amyotrophic labaran sclerosis: Drug, nutritional and respiratory therapies (wata hujja mai shaida): Rahoton Tsarin Ɗaukaka Ƙwararren Cibiyar Nazarin Kasuwancin Amirka. Bincike na 2009; 73; 1218-1226.
> Sanya S, Carvalho MD. Rayuwa da sabon rayuwa a cikin maganin cigaba don rashin ciwo na numfashi a cikin marasa lafiya na sclerosis na launi amyotrophic. Gyaran Kwayoyin Neurodegenerative Disease . 2014; 4 (1): 83-102. Doi: 10.2217 / nmt.13.74.